Guggenheim analyst Jonathan Lee lowered the firm’s price target on Endava (DAVA) to $15 from $18 and keeps a Buy rating on the shares. Quarterly underperformance and a negative revision to the company’s FY26 outlook overshadow management’s incremental confidence in large deals, says the analyst, whose lower target reflects uncertainty in the near term.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava Reports Q1 FY2026 Revenue Decline Amid Challenges
- Endava’s Earnings Call: Strategic Wins Amid Financial Hurdles
- Endava’s Financial Struggles and Transition Challenges Lead to Hold Rating
- Endava downgraded to Market Perform from Outperform at William Blair
- Midday Fly By: SoftBank exits Nvidia, CoreWeave cuts guidance